Biotech startup PopVax begins human trials of fridge-stable covid vaccine
PopVax's PVX-001 is designed to remain stable at 2-8°C for at least nine months and protect against a broad range of covid-19 variants
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)